Skip to main content

Table 1 Characteristics of participants at baseline according to the incidence of major adverse cardiovascular event over the 7-year follow-up

From: Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study

  Major cardiovascular event
No (N = 210) Yes (N = 22) p
Age (years) 50.54 ± 16.76 60.56 ± 13.30 0.007
Sex men 121 (57.6) 17 (77.2) 0.07
BMI (kg/m2) 24.7 ± 3.7 27.1 ± 6.3 0.09
Diabetes duration (years) 20.6 ± 12.8 29.6 ± 17.8 0.03
HbA1c (mmol/ml) in 2009 (%) 7.6 ± 1.0 7.5 ± 1.0 0.74
Insulin pump 40 (19.0) 5 (22.7) 0.77
Smoking habits (n = 219) 51 (25.8) 4 (18.1) 0.43
HDL (g/l) (n = 222) 0.64 ± 0.19 0.58 ± 0.17 0.17
LDL (g/l) (n =t221) 1.03 ± 0.29 1.04 ± 0.33 0.88
Triglycerides (g/l) (n = 205) 0.89 ± 0.63 1.11 ± 0.53 0.13
Statin at baseline (n = 222) 45 (22.5) 13 (59.0) 0.0002
Hypertension 87 (41.43) 18 (81.82) 0.0003
Previous history of MACE 13 (6.19) 10 (45.45) < 0.0001
eGFR (mL/min) (n = 225)
 ≥ 60 179 (88.18) 13 (59.09) 0.001
 < 60 24 (11.82) 9 (40.91)  
Albumin excretion rate (mg/24 h) (n = 227)
 < 30 179 (86.89) 12 (57.14) 0.002
 ≥ 30 27 (13.11) 9 (42.86)  
 SAF (AU) 2.08 (0.54) 2.63 (0.73) 0.002
  1. Data presented in N (%) and mean ± standard deviation
  2. p value: COX test for qualitative variables and quantitative variables